Comparative Lipid-Lowering/Increasing Efficacy of 7 Statins in Patients with Dyslipidemia, Cardiovascular Diseases, or Diabetes Mellitus: Systematic Review and Network Meta-Analyses of 50 Randomized Controlled Trials

Figure 4

Network plots of eligible comparisons for (a) LDL-C change value, (b) HDL-C change value, (c) TC change value, (d) TG change value, (e) ApoA1 change value, and (f) ApoB change value among placebo and different statin treatments. The size of the nodes is weighted according to the number of trials available for each treatment. The treatments for which direct comparisons were available are linked with a line. The thickness of the line corresponds to the inverse variance of the direct comparisons which is a proxy for the sample size.

(a)

(b)

(c)

(d)

(e)

(f)